Netapp, Inc.

Abbvie Inc.

Rui Wang

Chung-Ming Hsieh

Lorenzo Benatuil

Maria A Argiriadi

Kevin Faulkner

Gillian A Kingsbury

Bradford L McRae

John E Harlan

Joseph Weihs

David A Egan

Russell A Judge

The present invention encompasses antagonist anti-CD40 antibodies and antigen-binding portions thereof. Specifically, the invention relates to humanized anti-CD40 antibodies. In certain embodiments, antibodies of the invention neutralize human CD40 (hCD40) activity. Antibodies, or antibody portions, of the invention are useful for detecting CD40 and for inhibiting CD40 activity, e.g., in a human subject suffering from a disorder in which CD40 activity is detrimental.

Anti-CD40 antibodies

Methods and systems for monitoring quality of service (QOS) data for a plurality of storage volumes from a storage operating system of a storage system are provided. A performance manager collects QOS data for a storage volume from among the plurality of storage volumes and the QOS data includes a response time in which the storage volume responds to an input/output (I/O) request; determines that the collected QOS data is noisy by comparing an average number of I/O requests processed within a time duration for the storage volume with a first threshold value; uses comparable QOS data of another storage volume for generating an expected range for future QOS data; and monitors QOS data for the storage volume for determining whether a current QOS data for the storage volume is within the expected range.

Methods and systems for filtering collected QOS data for predicting an expected range for future QOS data

Growing community of inventors

Newton, MA, United States of America

Rui Wang